The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)
Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in microbiology, total microbiology market), by pathogen/disease (healthcare-acquired infections / antimicrobial resistance, STDs / women's health, hepatitis, HIV, respiratory tract infections, others), and by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world).
The report also looks at the global microbiology/infectious disease immunoassay 2017-2022 market by segment (laboratory-based immunoassays, rapid/point-of-care immunoassays, total microbiology/infectious disease immunoassay market), by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world), and by pathogen/disease indication (hepatitis, HIV, STDs, TORCH, respiratory, sepsis, parasitology, mycology, others).
There is a need for rapid tests that can quickly identify a microbial pathogen, and (if the pathogen is a bacteria) identify what antibiotic will be effective in treating the infection – all before a physician makes the treatment decision. This ideal test does not yet exist, but considerable advances are occurring in fields such as molecular microbiology and mass spectrometry in the microbiology laboratory. In addition, new technologies and platforms are being developed by companies that are working towards development of this much needed test. Beckman Coulter, Becton Dickinson, bioMérieux, and Thermo Fisher Scientific are among the market companies profiled in the report.91
- Executive Summary
- Overview
- Scope and Methodology
- Market Overview
- Table Worldwide Microbiology Market, by Segment, 2017-2022 (in millions USD)
- Introduction
- The Microbiology Laboratory
- Traditional Microbiology – Microbial Identification and Antibiotic Susceptibility Testing (ID/AST)
- Advances in Microbiology
- The Quest for Rapid Microbial Identification/Antibiotic Susceptibility (Resistance) Tests
- Table Moving Towards the Goal of Rapid Microbial Identification and Antibiotic Resistance/Susceptibility Testing – Evolution towards a Platform that Combines Desired Characteristics of Different Technologies
- Point-of-View and Methodology
- Why Care about What Is Happening in Microbiology? Infectious Disease Trends
- Burden of Infectious Disease
- Emerging Threats
- The Problem of Microbial Antibiotic Resistance
- Limitations of Traditional Microbiology
- Needed: Rapid Microbial Identification and Antibiotic Susceptibility/Resistance Tests
- Selected Technologies/Platforms in Microbiology Laboratories
- Traditional Microbiology
- Overview of Traditional Microbial ID/AST
- Table Microbiology Sample/Specimen Types Ranked by Average Volume
- ID/AST Systems, and Panels and Reagents for ID/AST Systems
- Table Major Companies Marketing Microbial ID/AST Systems
- Chromogenic Media
- Table Selected Companies Marketing Chromogenic Media
- Rapid Tests Performed on Colonies from Culture Media
- Blood Culture
- Table Selected Companies Marketing Blood Culture Systems
- Overview of Traditional Microbial ID/AST
- Mass Spectrometry
- Table Mass Spectrometry Companies in Microbiology
- Immunoassays
- Traditional Rapid Immunoassay Technologies – Flow Through Assays and Immunochromatographic (Lateral Flow) Tests
- Enzyme Immunoassays
- Polymerase Chain Reaction and Other Nucleic Acid Amplification Technologies
- Table Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology
- Traditional Microbiology
- Advances in the Microbiology Laboratory
- Liquid Microbiology and ID/AST Automation
- Advances in Microbial Identification Following Blood Culture
- Mass Spectrometry
- PCR and Other NAAT Based Tests for Infectious Diseases
- Next Generation Sequencing
- Table Selected Companies Applying DNA/RNA Sequencing to Microbiology
- Applications and Advances in Molecular Microbiology
- Applications of Molecular Testing in the Microbiology Laboratory – Selected Examples
- Sexually Transmitted Diseases and Women's Health
- Hepatitis
- HIV
- Hospital-Acquired Infections (HAIs)
- Respiratory Infections
- Tuberculosis
- Multiplex Tests and Syndromic Testing
- What is Syndromic Testing and Why is ii Important?
- When Should Syndromic Testing Be Performed? Syndromic Testing versus Traditional Single or Duplex Multiple Diagnostic Tests
- DNA and RNA Sequencing in Microbiology
- Applications of Molecular Testing in the Microbiology Laboratory – Selected Examples
- Rapid Microbiology
- "Rapid" Testing in Microbiology Labs Today – Faster Than Traditional Microbiology, But…
- Making Progress – Development of Faster Identification and Antimicrobial Susceptibility/Resistance Tests for the Microbiology Lab and Near Patient or Point-of-Care
- Table Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
- Corporate Deals in Microbiology
- Investments and Financing Agreements
- Table Selected Investment and Financing Agreements in Microbiology
- Merger and Acquisitions
- Table Selected Acquisitions of Microbiology Companies
- Corporate Agreements and Collaborations
- Table Selected Agreements between Microbiology Companies and Other Companies
- Microbiology Company Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
- Table Selected Microbiology Company Agreements with Academia or Other Non-Profit Organizations
- Investments and Financing Agreements
- Market Drivers, Challenges, and Trends in Microbiology
- Cost of Molecular Microbiology Tests versus Traditional Microbiology
- Clinical Market Drivers
- Near-Patient and Point-of-Care Testing Market Drivers and Challenges/Hurdles
- Competition
- Regulation
- Reimbursement
- Future Prospects
- Microbiology Market Analysis
- Worldwide Microbiology Market
- Table Worldwide Microbiology Market, by Segment, 2017-2022 (in millions USD)
- Table Major Pathogens/Disease Indications in Microbiology/Infectious Disease Market, 2017 (%)
- Table Worldwide Microbiology Market, by Geographic Region, 2017-2022 (in millions USD)
- Traditional Microbiology ID/AST Market
- Microbial Identification and Antimicrobial Susceptibility Systems
- Blood Culture
- Chromogenic Media
- Rapid Tests Performed on Colonies from Culture Media
- Table Worldwide Traditional Microbiology Market, by Segment, 2017-2022 (in millions USD)
- Table Worldwide Traditional Microbiology Market, by Geographic Region, 2017-2022 (in millions USD)
- Table Market Shares of Selected Companies in the Traditional Microbiology Market (%)
- Microbiology/Infectious Disease Immunoassay Market
- Table Worldwide Microbiology/Infectious Disease Immunoassay Market, by Segment, 2017-2022 (in millions USD)
- Table Worldwide Microbiology/Infectious Disease Immunoassay Market, by Geographic Region, 2017-2022 (in millions USD)
- Table Worldwide Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (in millions USD)
- Table Worldwide Rapid Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (in millions USD)
- Molecular Microbiology Market
- Table Worldwide Molecular Microbiology Market, by Pathogen/Disease Indication, 2017-2022 (in millions USD)
- Table Worldwide Molecular Microbiology Market, by Geographic Region, 2017-2022 (in millions USD)
- Table Major Company Market Shares in Molecular Microbiology Diagnostic Testing (%)
- Microbiology Mass Spectrometry Market
- Table Worldwide Microbiology Mass Spectrometry Market, 2017-2022 (in millions USD)
- Future Market Potential for Rapid Microbial Identification and Antibiotic Susceptibility/Resistance Tests
- Worldwide Microbiology Market
- Company Profiles
- 3i Diagnostics, Inc. (3iDx)
- Abbott
- Recent Revenue History
- Table Abbott Revenues (2014 – 2016, plus first 9 months of 2017) (millions USD)
- Company Overview – With a Focus on Microbiology/Infectious Disease Diagnostics
- Recent Revenue History
- Accelerate Diagnostics, Inc.
- Recent Revenue History
- Table Accelerate Diagnostics, Inc. (2014 – 2017) (thousands USD)
- Company Overview
- Recent Revenue History
- Atlas Genetics Ltd.
- AutoGenomics, Inc.
- Beckman Coulter, Inc. (A Danaher Corporation Company)
- Revenue History
- Company Overview
- Becton, Dickinson and Company (BD)
- Recent Revenue History
- Table Becton, Dickinson and Co. Revenues (FY2015 to FY2017) (millions USD)
- Company Overview
- Recent Revenue History
- Bio-Rad Laboratories, Inc.
- Recent Revenue History
- Table Company Revenues (2014 – 2017) (thousands USD)
- Company Overview
- Recent Revenue History
- BioFire Diagnostics, LLC. (Acquired by bioMérieux)
- Recent Revenue History and Other Financial Information
- Company Overview
- bioMérieux SA
- Recent Revenue History
- Table bioMérieux Revenues (2015-2017) (millions euros)
- Company Overview
- Recent Revenue History
- Bruker Corporation
- Recent Revenue History
- Table Bruker Corporation Revenues (2014 – 2017) (millions USD)
- Company Overview:
- Recent Revenue History
- Cepheid (A Danaher Company)
- Recent Revenue History
- Table Company Revenues (2013 – 2015, last year available) (thousands USD)
- Company Overview
- Recent Revenue History
- COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
- Curetis
- Recent Revenue History
- Table Curetis N.V. Revenues (2015 – 2017)
- Company Overview
- Recent Revenue History
- DiaSorin S.p.A.
- Recent Revenue History
- Table DiaSorin Revenues (2015 – 2016, plus first nine months of 2017) (millions of euros)
- Company Overview
- Recent Revenue History
- ELITech Group
- GenePOC Inc.
- GenMark Diagnostics, Inc.
- Recent Revenue History
- Table GenMark Diagnostics Revenues (2014 – 2017) (thousands USD)
- Company Overview
- Recent Revenue History
- Hologic, Inc.
- Recent Revenue History
- Table Hologic, Inc. Revenues (FY2015 – FY2017) (millions USD)
- Company Overview
- Recent Revenue History
- Janssen Diagnostics (Janssen Pharmaceutical Companies of Johnson & Johnson)
- Luminex Corporation
- Recent Revenue History
- Table Luminex Corporation Revenues (2014 – 2017) (thousands USD)
- Company Overview
- Recent Revenue History
- Mast Group
- Q-linea AB
- QIAGEN N.V.
- Recent Revenue History
- Table Company Revenues (2015-2017) (thousands USD)
- Company Overview
- Recent Revenue History
- QuanDx Inc.
- QuantuMDx Group
- Quidel, Inc.
- Recent Revenue History
- Table Quidel Revenues (2015-2017) (thousands USD)
- Company Overview
- Recent Revenue History
- Qvella Corporation
- Rheonix, Inc.
- Roche
- Recent Revenue History
- Table Roche Revenues (2015-2017) (millions USD)
- Company Overview
- Recent Revenue History
- Siemens Healthineers
- Recent Revenue History
- Company Overview
- THERMO FISHER SCIENTIFIC INC
- Recent Revenue History
- Table Thermo Fisher Scientific (2015-2017) (million USD)
- Company Overview
- Recent Revenue History
- Xagenic Inc.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook